| Title | Author(s) | Year | View Count |
 | Occult hepatitis B virus reinfection after liver transplantation despite nucleoside analogues prophylaxis (Post Exhibition) | Cheung, CKY; Lau, G; Man, K; Lo, CM | 2009 | 90 |
 | World gastroenterology organisation practice guideline - hepatitis B September 2008 | Heathcote, J; Abbas, Z; Alberti, A; Benhamou, Y; Chen, C; Elewaut, A; Ferenci, P; Hui, C; Isakov, V; Janssen, H; Lau, G; Lira, S; Okanoue, T; OnoNita, S; Piratvisuth, T; Rizzetto, M; Sollano, I; Pearman, W; Yeh, CT; Yuen, M; Krabshuis, J | 2009 | 44 |
| Outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen | Hui, CK; Cheung, WW; Leung, KW; Cheng, VCC; Tang, SF; Li, WS; Lee, NP; Kwong, YL; Au, WY; Yuen, KY; Lau, G; Liang, RHS | 2008 | 125 |
| Occult hepatitis B virus reinfection in liver transplant recipient (Abstract) | Cheung, CKY; Lo, CM; Man, K; Lau, G; Fan, ST; Wong, J | 2008 | 123 |
| Occult hepatitis B virus reinfection in liver transplant recipient (Oral Presentation) | Cheung, CKY; Lo, CM; Man, K; Lau, G; Fan, ST; Wong, J | 2008 | 111 |
| Changes in liver histology as a surrogate endpoint of antiviral therapy for chronic HBV can predict progression to liver complications | Hui, CK; Leung, N; Shek, TWH; Zhang, H; Luk, JMC; Poon, RTP; Lo, CM; Fan, ST; Lau, G | 2008 | 109 |
| Identification of biomakers for the prediction of hepatitis B related hepatocellular carcinoma by integrated proteomics, The 17th Asian Pacific Association for the Study of the Liver Conference, Kyoto, Japan, 27 - 30 March 2007 | Zhu, R; Lei, T; Ng, M; Luk, JMC; Sham, P; Chiu, JF; Lau, G | 2007 | 97 |
| Identification of biomarkers for the prediction of HBV related HCC by integrated proteomics | Lau, G; Zhu, R; Lei, T; Ng, MY; Luk, JMC; Sham, P; Chiu, JF; He, QY | 2007 | 98 |
| The use of transient elastography as a preoperative assessment of hepatic resection (Abstract) | Lai, L; Hui, CK; Poon, RTP; Shek, TWH; Lai, ST; Lai, JY; Lo, CM; Fan, ST; Leung, N; Lau, G | 2007 | 118 |
| Proteomics of mouse liver from embryo to adult: a lesion for HCC (Abstract) | Lee, PY; Cheung, N; Lam, BYH; Sham, P; Lau, G; Fan, ST; Luk, JMC; Luk, JMC | 2007 | 78 |
| Identification of biomarkers for the prediction of HBV related HCC by integrated proteomics (Abstract) | Lau, G; Zhu, R; Lei, T; Ng, MY; Luk, JMC; Sham, P; Chiu, JF; He, QY | 2007 | 75 |
| A crucial role for dendritic cell (DC) IL-10 in inhibiting successful DC-based immunotherapy: superior antitumor immunity against hepatocellular carcinoma evoked by DC devoid of IL-10 | Chen, YX; Man, K; Ling, GS; Chen, Y; Sun, B; Cheng, Q; Wong, OH; Lo, CK; Ng, IOL; Chan, LC; Lau, G; Lin, SCL; Huang, F; Huang, FP | 2007 | 112 |
| Lentivirus-mediated RNA Interference Targeting Enhancer of Zeste Homolog 2 Inhibits Hepatocellular Carcinoma Growth Through Down-regulation of Stathmin (Erratum in: Hepatology. 2007 Oct;46(4):1314) | Chen, Y; Lin, MC; Yao, H; Wang, H; Zhang, AQ; Yu, J; Hui, CK; Lau, G; He, ML; Sung, J; Kung, HF | 2007 | 202 |
| In Vitro Anti-hepatitis B Virus Activities and Mechanism of Silver Nanoparticles,The 17th Asian Pacific Association for the Study of the Liver Conference, Kyoto, Japan, 27 - 30 March 2007 | Lu, L; Sun, RWY; Hui, CK; Chen, R; Luk, JMC; Che, CM; Lau, G | 2007 | 103 |
| Size-dependent anti-hepatitis B virus activities and mechanism of silver nanoparticles (Abstract) | Lu, L; Sun, RWY; Hui, CK; Chen, R; Luk, JMC; Che, CM; Lau, G | 2007 | 135 |
| Size-dependent anti-hepatic B virus activities and mechanism of silver nanoparticles | Lu, L; Sun, RWY; Hui, CK; Chen, R; Luk, JMC; Che, CM; Lau, G | 2007 | 95 |
| Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways (Review Article) | Sun, S; Lee, PY; Poon, RTP; Fan, ST; He, Q; Lau, G; Luk, JMC | 2007 | 109 |
| Serum adiponectin is increased in advancing liver fibrosis and decline with reduction in fibrosis in chronic hepatitis B | Zhang, H; Hui, CK; Lee, PY; Chan, W; Yueng, YH; Leung, KW; Lu, L; Leung, N; Lo, CM; Fan, ST; Luk, JMC; Xu, A; Lam, KSL; Kwong, YL; Lau, G | 2007 | 214 |
| Mortalin-2 is an accurate prognostic biomarker for early recurrence of liver carcinoma (Abstract) | Luk, JMC; Yi, X; Lee, PY; Guan, XY; Lau, G; Fan, ST | 2007 | 160 |
| Application of Microarray and Gas Chromatography-Mass Spectrometry Technologies to Investigate the Immunomodulatory Effects of Ginseng on Human Monocytic Cells | Lee, DCW; Chik, SCC; Yang, LH; Li, CB; Rong, J; Lau, G; Tam, PKH; Lau, ASY | 2007 | 97 |
|
